Gamma Interferon Mediates Experimental Cerebral Malaria by Signaling within Both the Hematopoietic and...

Area of Science:

• Immunology
• Neuroscience
• Infectious Diseases

Background:

• Experimental cerebral malaria (ECM) is a severe neurological complication dependent on gamma interferon (IFN-γ).
• The precise cellular targets and mechanisms through which IFN-γ orchestrates ECM remain incompletely understood.

Purpose of the Study:

• To elucidate the specific cell types and compartments targeted by IFN-γ in the development of ECM.
• To investigate the additive or synergistic roles of IFN-γ signaling in hematopoietic and nonhematopoietic cells during ECM pathogenesis.

Main Methods:

• Utilized genetically modified mice with cell- and compartment-specific deletion of the IFN-γ receptor 2 (IFN-γR2).
• Analyzed susceptibility to ECM in mice lacking IFN-γR2 on myeloid cells, T cells, neurons, or endothelial cells.
• Employed an in vitro system to assess synergistic effects of IFN-γ and TNF on brain endothelial cells.

Main Results:

• IFN-γ signaling in both hematopoietic and nonhematopoietic compartments is essential for ECM development, with additive effects on intracerebral inflammation.
• Mice lacking IFN-γR2 on myeloid cells, T cells, or neurons remained fully susceptible to fatal ECM, suggesting redundant or alternative targets within the hematopoietic compartment.
• Brain endothelial cells, but not neurons, were identified as a major nonhematopoietic target of IFN-γ in ECM pathogenesis, showing synergistic activation with TNF in vitro.

Conclusions:

• IFN-γ mediates ECM by acting additively on both immune and non-immune cells within the central nervous system.
• Within the hematopoietic compartment, IFN-γ may target non-T cell or non-myeloid populations redundantly.
• Brain endothelial cells are a key nonhematopoietic target of IFN-γ contributing to cerebral pathology in ECM.